Vestibular Anatomic Localization of Pain Sensitivity in Women with Insertional Dyspareunia: A Different Approach to Address the Variability of Painful Intercourse

The pathophysiology underlying painful intercourse is challenging due to variability in manifestations of vulvar pain hypersensitivity. This study aimed to address whether the anatomic location of vestibular-provoked pain is associated with specific, possible causes for insertional dyspareunia. Women (n = 113) were assessed for “anterior” and “posterior” provoked vestibular pain based on vestibular tenderness location evoked by a Q-tip test. Pain evoked during vaginal intercourse, pain evoked by deep muscle palpation, and the severity of pelvic floor muscles hypertonicity were assessed. The role of potential confounders (vestibular atrophy, umbilical pain hypersensitivity, hyper-tonus of pelvic floor muscles and presence of a constricting hymenal-ring) was analyzed to define whether distinctive subgroups exist. Q-tip stimulation provoked posterior vestibular tenderness in all participants (6.20 ± 1.9). However, 41 patients also demonstrated anterior vestibular pain hypersensitivity (5.24 ± 1.5). This group (circumferential vestibular tenderness), presented with either vestibular atrophy associated with hormonal contraception use (n = 21), or augmented tactile umbilical-hypersensitivity (n = 20). The posterior-only vestibular tenderness group included either women with a constricting hymenal-ring (n = 37) or with pelvic floor hypertonicity (n = 35). Interestingly, pain evoked during intercourse did not differ between groups. Linear regression analyses revealed augmented coital pain experience, umbilical-hypersensitivity and vestibular atrophy predicted enhanced pain hypersensitivity evoked at the anterior, but not at the posterior vestibule (R = 0.497, p < 0.001). Distinguishing tactile hypersensitivity in anterior and posterior vestibule and recognition of additional nociceptive markers can lead to clinical subgrouping.

[1]  A. Paetau,et al.  Immune activation enhances epithelial nerve growth in provoked vestibulodynia. , 2016, American journal of obstetrics and gynecology.

[2]  C. Pukall,et al.  Non-Medical, Medical, and Surgical Approaches for the Treatment of Provoked Vestibulodynia , 2016, Current Sexual Health Reports.

[3]  S. Witkin,et al.  Recent advances in understanding provoked vestibulodynia , 2016, F1000Research.

[4]  J. Bornstein,et al.  2015 ISSVD, ISSWSH and IPPS Consensus Terminology and Classification of Persistent Vulvar Pain and Vulvodynia , 2016, Obstetrics and gynecology.

[5]  Candace S. Brown,et al.  Vulvodynia: Assessment and Treatment. , 2016, The journal of sexual medicine.

[6]  G. Bachmann,et al.  Vulvodynia: Definition, Prevalence, Impact, and Pathophysiological Factors. , 2016, The journal of sexual medicine.

[7]  S. As-Sanie,et al.  Mucosal versus muscle pain sensitivity in provoked vestibulodynia , 2015, Journal of pain research.

[8]  M. Morin,et al.  Active and Passive Components of Pelvic Floor Muscle Tone in Women with Provoked Vestibulodynia: A Perspective Based on a Review of the Literature. , 2015, The journal of sexual medicine.

[9]  I. Goldstein,et al.  Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. , 2014, The journal of sexual medicine.

[10]  R. Rubin,et al.  Current Uses of Surgery in the Treatment of Genital Pain , 2014, Current Sexual Health Reports.

[11]  D. Foster,et al.  Vulvodynia: Current state of the biological science , 2014, PAIN®.

[12]  H. Lawson,et al.  2013 Vulvodynia Guideline Update , 2014, Journal of lower genital tract disease.

[13]  L. Burrows,et al.  The Treatment of Vestibulodynia with Topical Estradiol and Testosterone , 2013, Sexual medicine.

[14]  G. Essick,et al.  Reliability and reproducibility of novel methodology for assessment of pressure pain sensitivity in pelvis. , 2012, The journal of pain : official journal of the American Pain Society.

[15]  L. Burrows,et al.  The effects of hormonal contraceptives on female sexuality: a review. , 2012, The journal of sexual medicine.

[16]  K. Nilsson,et al.  Provoked vestibulodynia--medical factors and comorbidity associated with treatment outcome. , 2012, The journal of sexual medicine.

[17]  Ananda Sen,et al.  Prevalence and demographic characteristics of vulvodynia in a population-based sample. , 2012, American journal of obstetrics and gynecology.

[18]  G. Donders,et al.  Characteristics of the pain observed in the focal vulvodynia syndrome (VVS). , 2012, Medical Hypotheses.

[19]  T. Morgan,et al.  Differences in Primary Compared With Secondary Vestibulodynia by Immunohistochemistry , 2011, Obstetrics and gynecology.

[20]  J. Andrews Vulvodynia Interventions—Systematic Review and Evidence Grading , 2011, Obstetrical & gynecological survey.

[21]  G. Ohel,et al.  The association between supra‐physiological levels of estradiol and response patterns to experimental pain , 2010, European journal of pain.

[22]  I. Goldstein,et al.  Can oral contraceptives cause vestibulodynia? , 2010, The journal of sexual medicine.

[23]  L. McLean,et al.  Pelvic floor muscle assessment outcomes in women with and without provoked vestibulodynia and the impact of a physical therapy program. , 2010, The journal of sexual medicine.

[24]  A. Goldstein Moving beyond the diagnosis of vestibulodynia--a holiday wish list. , 2009, The journal of sexual medicine.

[25]  L. Burrows,et al.  Umbilical hypersensitivity in women with primary vestibulodynia. , 2008, The Journal of reproductive medicine.

[26]  A. Vitonis,et al.  Influence of oral contraceptive use on the risk of adult-onset vulvodynia. , 2008, The Journal of reproductive medicine.

[27]  A. Malykhina Neural mechanisms of pelvic organ cross-sensitization , 2007, Neuroscience.

[28]  R. Craft Modulation of pain by estrogens , 2007, PAIN.

[29]  Z. Ben-Aroya,et al.  Vulvar vestibulitis syndrome and estrogen dose of oral contraceptive pills. , 2007, The journal of sexual medicine.

[30]  M. Hilliges,et al.  The vulval vestibular mucosa—morphological effects of oral contraceptives and menstrual cycle , 2007, The British journal of dermatology.

[31]  M. Granot,et al.  Psychological Factors Associated with Perception of Experimental Pain in Vulvar Vestibulitis Syndrome , 2005, Journal of sex & marital therapy.

[32]  Y. Binik,et al.  Pelvic floor muscle functioning in women with vulvar vestibulitis syndrome , 2005, Journal of psychosomatic obstetrics and gynaecology.

[33]  I. Ben‐Ami,et al.  The Major Histopathologic Characteristics in the Vulvar Vestibulitis Syndrome , 2005, Gynecologic and Obstetric Investigation.

[34]  E. Torebjörk,et al.  Decreased mechanical pain threshold in the vestibular mucosa of women using oral contraceptives: a contributing factor in vulvar vestibulitis? , 2004, The Journal of reproductive medicine.

[35]  J. Bornstein,et al.  Hyperinnervation and Mast Cell Activation May Be Used as Histopathologic Diagnostic Criteria for Vulvar Vestibulitis , 2004, Gynecologic and Obstetric Investigation.

[36]  Y. Binik,et al.  Vaginal Spasm, Pain, and Behavior: An Empirical Investigation of the Diagnosis of Vaginismus , 2004, Archives of sexual behavior.

[37]  G. Terenghi,et al.  Increased innervation of the vulval vestibule in patients with vulvodynia , 2003, The British journal of dermatology.

[38]  H. Stenlund,et al.  Prevalence and incidence of prolonged and severe dyspareunia in women: results from a population study , 2003, Scandinavian journal of public health.

[39]  J. Brisson,et al.  Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. , 2002, American journal of epidemiology.

[40]  R. Amsel,et al.  Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome , 2002, Pain.

[41]  L. Wise,et al.  Prevalence and predictors of chronic lower genital tract discomfort. , 2001, American journal of obstetrics and gynecology.

[42]  M. Hilliges,et al.  Neurochemical Characterization of the Vestibular Nerves in Women with Vulvar Vestibulitis Syndrome , 1999, Gynecologic and Obstetric Investigation.

[43]  E. Laumann,et al.  Sexual dysfunction in the United States: prevalence and predictors. , 1999, JAMA.

[44]  M. Hilliges,et al.  Increased Intraepithelial Innervation in Women with Vulvar Vestibulitis Syndrome , 1998, Gynecologic and Obstetric Investigation.

[45]  R. Willén,et al.  Vestibular Nerve Fiber Proliferation in Vulvar Vestibulitis Syndrome , 1998, Obstetrics and gynecology.

[46]  I. Sjöberg,et al.  Vulvar vestibulitis in the north of Sweden. An epidemiologic case-control study. , 1997, The Journal of reproductive medicine.

[47]  J. Brisson,et al.  Vulvar Vestibulitis Syndrome: An Exploratory Case-Control Study , 1994, Obstetrics and gynecology.

[48]  L. Fertitta,et al.  Vulvar vestibulitis syndrome. , 1992, Nurse practitioner forum.

[49]  L. Grillo,et al.  Mangement of dyspareunia secondary to hymenal remnants. , 1980, Obstetrics and Gynecology.